We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRV icon
651
Travelers Companies
TRV
$82.9B
$367K 0.04%
1,568
-10,845
-87% -$2.39M
WRB icon
652
W.R. Berkley
WRB
$28.3B
$366K 0.04%
+6,459
New +$363K
VRNT
653
DELISTED
Verint Systems
VRNT
$364K 0.04%
+14,380
New +$443K
MBLY icon
654
Mobileye
MBLY
$2.13B
$363K 0.04%
+26,524
New +$465K
PAGS icon
655
PagSeguro Digital
PAGS
$2.69B
$363K 0.04%
+42,170
New +$488K
GFS icon
656
GlobalFoundries
GFS
$26.9B
$363K 0.04%
+9,010
New +$418K
MSM icon
657
MSC Industrial Direct
MSM
$6.97B
$358K 0.04%
+4,158
New +$340K
AORT icon
658
Artivion
AORT
$1.31B
$358K 0.04%
+13,441
New +$349K
PERI icon
659
Perion Network
PERI
$378M
$357K 0.04%
45,349
-1,792
-4% -$15K
PAYC icon
660
Paycom
PAYC
$7.54B
$357K 0.04%
+2,145
New +$343K
ALSN icon
661
Allison Transmission
ALSN
$10B
$355K 0.04%
+3,692
New +$317K
VERX icon
662
Vertex
VERX
$2.14B
$353K 0.04%
9,158
+2,328
+34% +$85.8K
BCE icon
663
BCE
BCE
$20.3B
$352K 0.04%
10,104
-28,326
-74% -$967K
KBR icon
664
KBR
KBR
$4.74B
$351K 0.04%
5,383
+247
+5% +$16.1K
DASH icon
665
DoorDash
DASH
$85.2B
$351K 0.04%
+2,456
New +$298K
ROK icon
666
Rockwell Automation
ROK
$52.4B
$350K 0.04%
+1,305
New +$346K
TTEC icon
667
TTEC Holdings
TTEC
$119M
$350K 0.04%
59,666
+17,810
+43% +$97.1K
SNDX icon
668
Syndax Pharmaceuticals
SNDX
$1.74B
$348K 0.04%
+18,070
New +$373K
HSTM icon
669
HealthStream
HSTM
$843M
$348K 0.04%
12,060
+696
+6% +$19.9K
OWL icon
670
Blue Owl Capital
OWL
$6.63B
$346K 0.04%
17,890
-13,176
-42% -$235K
FOLD
671
DELISTED
Amicus Therapeutics
FOLD
$346K 0.04%
+32,358
New +$352K
NUE icon
672
Nucor
NUE
$60.5B
$345K 0.04%
+2,298
New +$346K
CRNX icon
673
Crinetics Pharmaceuticals
CRNX
$8.88B
$344K 0.04%
+6,727
New +$347K
ADTN icon
674
Adtran
ADTN
$730M
$343K 0.04%
57,809
-66,209
-53% -$369K
AQN icon
675
Algonquin Power & Utilities
AQN
$4.68B
$343K 0.04%
62,874
-133,672
-68% -$760K
25 26
27
28 29

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.